- Trials with a EudraCT protocol (7,257)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10,738)
7,257 result(s) found.
Displaying page 1 of 363.
EudraCT Number: 2007-001996-13 | Sponsor Protocol Number: Tirofiban-Urokinasi 2007 | Start Date*: 2007-06-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Intravenous glycoprotein IIbIIIa inhibitor (Tirofiban) combined with low dose of intra-arterial Urokinase for the endovascolar treatment of patients with acute major ischemic stroke | |||||||||||||
Medical condition: patients with major ischemic stroke not suitable for other authorized treatment for riperfusion of the ischemic area | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001368-35 | Sponsor Protocol Number: 31520 | Start Date*: 2008-04-24 | |||||||||||
Sponsor Name:Oulu University Hospital | |||||||||||||
Full Title: Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants | |||||||||||||
Medical condition: Study population: Children born extremely preterm (before 28 weeks of gestation). Primary outcome: 1) Death before a corrected age of 18 months and survival with severe disability. 2) The growth ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004068-74 | Sponsor Protocol Number: ZEPLAST-PED | Start Date*: 2019-09-26 | |||||||||||
Sponsor Name:I.R.C.C.S. POLICLINICO SAN DONATO | |||||||||||||
Full Title: ZEro_PLASma Trial in small infants undergoing cardiac surgery | |||||||||||||
Medical condition: Congenital heart disease | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000201-69 | Sponsor Protocol Number: D5290C00005 | Start Date*: 2019-08-13 | |||||||||||
Sponsor Name:MedImmune, LLC | |||||||||||||
Full Title: A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-... | |||||||||||||
Medical condition: The prevention of medically attended RSV LRTI. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) LV (Completed) GB (GB - no longer in EU/EEA) SE (Completed) DE (Completed) BG (Completed) CZ (Completed) EE (Completed) HU (Completed) LT (Ongoing) PL (Completed) FI (Completed) AT (Completed) FR (Ongoing) ES (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016877-14 | Sponsor Protocol Number: H1N1-2009 | Start Date*: 2009-11-04 |
Sponsor Name:COPSAC | ||
Full Title: H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women | ||
Medical condition: Protection against Influenza A H1N1v disease | ||
Disease: | ||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010722-19 | Sponsor Protocol Number: BI71023_3001 | Start Date*: 2009-11-04 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congenital Factor XIII Deficiency Estudio prospectivo, multicéntrico, con et... | |||||||||||||
Medical condition: Congenital Factor XIII deficiency Deficiencia congénita de factor XIII | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022370-14 | Sponsor Protocol Number: 1015202 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Centre Hospitalier de Toulouse | |||||||||||||
Full Title: Evaluation de la tolérance d'une administration intra-nasale d'ocytocine chez des nourrissons présentant un syndrome de Prader-Willi et de son effet sur la succion et la prise alimentaire. | |||||||||||||
Medical condition: Syndrome de Prader Willi | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005612-28 | Sponsor Protocol Number: 2011-11-11 | Start Date*: 2012-02-27 | ||||||||||||||||
Sponsor Name:Hannu Kokki | ||||||||||||||||||
Full Title: Pharmacokinetics of oxycodone in preterm and in infants | ||||||||||||||||||
Medical condition: Severe pain states which need oxycodone analgesia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003567-22 | Sponsor Protocol Number: Zincox12 | Start Date*: 2012-12-05 | |||||||||||
Sponsor Name:A.O. UNIVERSITARIA INTEGRATA DI VERONA | |||||||||||||
Full Title: Efficacy of topical application of zinc oxide ointment compared with zinc oxide paste and tocoferol, for treating diaper dermatitis in infant: a randomized, controlled, triple blind study | |||||||||||||
Medical condition: Diaper dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002342-21 | Sponsor Protocol Number: KB055 | Start Date*: 2014-07-29 |
Sponsor Name:Kedrion S.P.A | ||
Full Title: | ||
Medical condition: | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001189-40 | Sponsor Protocol Number: 3 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:University of Tartu | ||||||||||||||||||||||||||||
Full Title: PHARMACOKINETICS OF ORAL SPIRONOLACTONE IN CHILDREN UP TO 2 YEARS OF AGE | ||||||||||||||||||||||||||||
Medical condition: cardiac failure, ascites and/or oedema | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: EE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001024-31 | Sponsor Protocol Number: 08/S0501/31 | Start Date*: 2008-08-27 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A randomised controlled trial of iodide supplementation in preterm infants with follow-up at 2 years | |||||||||||||
Medical condition: Transient hyothyroxinaemia | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005738-12 | Sponsor Protocol Number: LIPSTIC.V.01 | Start Date*: 2013-03-27 |
Sponsor Name:Alder Hey Children's NHS Foundation Trust | ||
Full Title: Liverpool Pharmacokinetic/pharmacodynamics study of teicoplanin in children (LIPSTIC). | ||
Medical condition: Gram-positive bacterial infection: late-onset neonatal sepsis, central line-associated blood stream infection, ventilator-associated pneumonia. | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002823-27 | Sponsor Protocol Number: GAVALAGG | Start Date*: 2016-11-17 | |||||||||||
Sponsor Name:INFECTOPHARM Arzneimittel GmbH | |||||||||||||
Full Title: Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe v... | |||||||||||||
Medical condition: Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001169-18 | Sponsor Protocol Number: UoL001360 | Start Date*: 2018-10-15 | ||||||||||||||||
Sponsor Name:University Of Liverpool | ||||||||||||||||||
Full Title: The efficacy and mechanism of surfactant therapy for critically ill infants with bronchiolitis: The Bronchiolitis Endotracheal Surfactant Study. | ||||||||||||||||||
Medical condition: Critical Illness due to Bronchiolitis of infancy requiring conventional invasive Mechanical Ventilation (MV) Diagnosis of bronchiolitis per clinical criteria defined in national guidance NICE-NG9. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001113-21 | Sponsor Protocol Number: NDPHRECOVERY | Start Date*: 2020-03-17 | ||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||
Full Title: Randomised Evaluation of COVID-19 Therapy (RECOVERY) | ||||||||||||||||||
Medical condition: COVID-19 (infection with SARS-CoV-2 virus) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016731-34 | Sponsor Protocol Number: CRO1413 | Start Date*: 2010-01-08 | |||||||||||
Sponsor Name:Imperial College | |||||||||||||
Full Title: Amino acid regimen and intravenous lipid composition in preterm parenteral nutrition: a randomised double blind controlled trial of Nutritional Evaluation and Optimisation in Neonates. | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011789-26 | Sponsor Protocol Number: IELSG30 | Start Date*: 2010-01-25 | |||||||||||
Sponsor Name:IELSG-International Extranodal Lymphoma Study Group | |||||||||||||
Full Title: A phase II study of R-CHOP with intensive CNS prophylaxis and scrotal irradiation in patients with primary testicular diffuse large B-cell lymphoma | |||||||||||||
Medical condition: primary testicular lymphoma diffuse large B-cell | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004775-30 | Sponsor Protocol Number: Na | Start Date*: 2018-05-09 |
Sponsor Name:Kirsi Mikkonen/Helsinki University Hospital | ||
Full Title: PREDICTION AND PREVENTION OF INFANTILE SPASMS IN HIGH RISK CHILDREN | ||
Medical condition: | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002345-39 | Sponsor Protocol Number: Göteborg University | Start Date*: 2006-02-16 |
Sponsor Name:NOPHO NHL-group | ||
Full Title: B-NHL BFM 04 | ||
Medical condition: B-cell lymphoma or B-ALL in children up to 18 years of age | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
